Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Konig et al., Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2020-217690
https://c19hcq.org/konig.html